It has been reported that 6BIO, a potent inhibitor of GSK-3α/β, has made a promising impact on age-associated diseases such as cancer and neurodegenerative diseases (Beurel et al., 2015; McCubrey et al., 2016). Here, GSK3A is linked to neurodegenerative disease.